These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 902673

  • 1. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.
    Andreasen F, Mikkelsen E.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):15-22. PubMed ID: 902673
    [Abstract] [Full Text] [Related]

  • 2. Effect of furosemide in congestive heart failure.
    Nomura A, Yasuda H, Minami M, Akimoto T, Miyazaki K, Arita T.
    Clin Pharmacol Ther; 1981 Aug 17; 30(2):177-82. PubMed ID: 7249502
    [Abstract] [Full Text] [Related]

  • 3. Hydralazine and furosemide kinetics.
    Nomura A, Yasuda H, Katoh K, Akimoto T, Miyazaki K, Arita T.
    Clin Pharmacol Ther; 1982 Sep 17; 32(3):303-6. PubMed ID: 7105621
    [Abstract] [Full Text] [Related]

  • 4. The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.
    Andreasen F, Christensen CK, Jakobsen FK, Mogensen CE.
    Acta Pharmacol Toxicol (Copenh); 1981 Sep 17; 49(3):223-9. PubMed ID: 7336980
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A, Goldman S, Edelen JS, Benet LZ, Cohn K.
    Pharmacology; 1979 Sep 17; 19(3):121-31. PubMed ID: 523503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Furosemide disposition in cirrhosis.
    Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA.
    Clin Pharmacol Ther; 1982 Jun 17; 31(6):719-25. PubMed ID: 7075120
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. On the fate of furosemide in man.
    Beermann B, Dalén E, Lindström B, Rosén A.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):51-61. PubMed ID: 1233253
    [Abstract] [Full Text] [Related]

  • 14. Bumetanide and furosemide in heart failure.
    Brater DC, Day B, Burdette A, Anderson S.
    Kidney Int; 1984 Aug 10; 26(2):183-9. PubMed ID: 6503136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R, Hoppel C, Ingalls ST.
    Clin Pharmacol Ther; 1981 Oct 10; 30(4):461-7. PubMed ID: 7285480
    [Abstract] [Full Text] [Related]

  • 17. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG.
    Circulation; 1994 Jul 10; 90(1):220-4. PubMed ID: 8026000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.